GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UFP Technologies Inc (NAS:UFPT) » Definitions » Cash Conversion Cycle

UFP Technologies (UFP Technologies) Cash Conversion Cycle : 111.31 (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is UFP Technologies Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

UFP Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 56.38.
UFP Technologies's Days Inventory for the three months ended in Dec. 2023 was 84.73.
UFP Technologies's Days Payable for the three months ended in Dec. 2023 was 29.8.
Therefore, UFP Technologies's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 111.31.


UFP Technologies Cash Conversion Cycle Historical Data

The historical data trend for UFP Technologies's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UFP Technologies Cash Conversion Cycle Chart

UFP Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.82 94.27 102.13 87.81 106.20

UFP Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.33 99.90 104.70 107.06 111.31

Competitive Comparison of UFP Technologies's Cash Conversion Cycle

For the Medical Devices subindustry, UFP Technologies's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UFP Technologies's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UFP Technologies's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where UFP Technologies's Cash Conversion Cycle falls into.



UFP Technologies Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

UFP Technologies's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=54.54+78.45-26.79
=106.20

UFP Technologies's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=56.38+84.73-29.8
=111.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


UFP Technologies  (NAS:UFPT) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


UFP Technologies Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of UFP Technologies's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


UFP Technologies (UFP Technologies) Business Description

Traded in Other Exchanges
Address
100 Hale Street, Newburyport, MA, USA, 01950-3504
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing highly specialized foams, films, and plastics primarily for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Executives
R Jeffrey Bailly director, 10 percent owner, officer: President and CEO 100 HALE STREET, NEWBURYPORT MA 01950
Mitchell Rock officer: Vice President C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833
Jason Holt officer: Vice President 100 HALE STREET, NEWBURYPORT MA 01950
Symeria Hudson director 100 HALE STREET, NEWBURYPORT MA 01950
Joseph Hassett director ONE TECHNOLOGY WAY, NORWOOD MA 02062
Daniel C Croteau director C/O LYNCH, BREWER, HOFFMAN & FINK, LLP, 75 FEDERAL STREET, 7TH FLOOR, BOSTON MA 02110
Cynthia L Feldmann director 17 WINTHROP ROAD, WAYLAND MA 01778
Christopher P. Litterio officer: Senior Vice President C/O UFP TECHNOLOGIES, INC., 100 HALE STREET, NEWBURYPORT MA 02143
Ronald J Lataille officer: Chief Financial Officer
Thomas Oberdorf director C/O GETTY IMAGES, INC., 601 N 34TH ST, SEATTLE WA 98103
Marc D Kozin director
Steve Cardin officer: Vice President 100 HALE STREET, NEWBURYPORT MA 01950
Daniel J Shaw officer: Vice President
W David Smith officer: Vice President 172 EAST MAIN STREET, GEORGETOWN MA 01833
Pierce Robert W Jr director C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833